2.65Open2.65Pre Close0 Volume355 Open Interest20.00Strike Price0.00Turnover134.39%IV9.16%PremiumJul 19, 2024Expiry Date0.90Intrinsic Value100Multiplier14DDays to Expiry1.75Extrinsic Value100Contract SizeAmericanOptions Type-0.5103Delta0.0767Gamma7.42Leverage Ratio-0.0687Theta-0.0046Rho-3.78Eff Leverage0.0155Vega
Kiniksa Pharmaceuticals International Stock Discussion
$Regenxbio(RGNX.US)$ Phase 2
$Leap Therapeutics(LPTX.US)$ Phase 2
$4D Molecular Therapeutics(FDMT.US)$ Phase 2
$Adverum Biotechnologies(ADVM.US)$ Phase 2
$Denali Therapeutics(DNLI.US)$ Phase 2
$EyePoint Pharmaceuticals(EYPT.US)$ Phase 2
$Xencor(XNCR.US)$ Phase 2
$Harmony Biosciences(HRMY.US)$ Phase 2
$Alnylam Pharmaceuticals(ALNY.US)$ Phase 2
$Disc Medicine(IRON.US)$ Phase 2
$Atea Pharmaceuticals(AVIR.US)$ Phase 2
$Allakos(ALLK.US)$ Phase 2 ...
i) Current market- $SPDR S&P 500 ETF(SPY.US)$
ii) Oil price
iii) My trade based on stage analysis
i) To be honest, after the last month CPI showed that the inflation is still not under controlled, the big sell off volume ha...
No comment yet